Scotland and Newcastle Lymphoma Group Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1993
NCT00003639
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1994

Timeline

NOW
  • Now